Skip to search formSkip to main contentSkip to account menu

CGP 41251

Known as: CGP 41 251, CGP-41251 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Alkaloidsmidostaurin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Antitumor Effect of CGP 41251 , a New Selective Protein Kinase C Inhibitor , on Human Non-Small Cell Lung Cancer Cells
The antitumor effect of CGP41251 (4'-N-benzoyl staurosporine), a selective protein kinase C (PKC) inhibitor, was examined on two… 
2006
2006
Signal Transduction Pathways by the Staurosporine Derivative C-mediatedPlatelet-derived Growth Factor-, and Protein Kinase Differential Inhibition of the Epidermal Growth Factor-, Updated Version
The microbial alkaloid Staurosporine is a potent but nonselective inhibitor of protein kinases. The derivative CGP 41251 has been… 
1998
1998
Clinical treatment with CGP 41251 increases sensitivity of CLL cells to conventional therapy
1997
1997
Preliminary results of a phase 2 study on a protein kinase C inhibitor (CGP 41251) in low grade lymphoproliferative disorders.
1996
1996
Effects of inhibitors of protein kinase C in drug sensitive and multidrug resistant Mcf-7 breast carcinoma cells
The hypothesis was tested that 9 kinase inhibitors with diverse specificities for protein kinase C (PKC), including stauro… 
1990
1990
Transformation by a ras Oncogene Causes Increased Expression of Protein Kinase C-a and Decreased
Rat embryo fibroblasts and liver epithelial cell lines normally express two isoforms of protein kinase C (PKC), PKC,, and PKC…